FSCN1 and cancer: It has been shown that exosomal LINC01711 dampens the activity of miR-326, which targets fascin actin-bundling protein 1 (FSCN1), in recipient cancer cells, hence expediting proliferation, migration, and invasion [131] (Figure 4 and Table 2).